FIRST MANHATTAN CO. LLC. - EPIPHANY TECHNOLOGY ACQUISIT ownership

EPIPHANY TECHNOLOGY ACQUISIT's ticker is EPHY and the CUSIP is 29429X109. A total of 1 filers reported holding EPIPHANY TECHNOLOGY ACQUISIT in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of EPIPHANY TECHNOLOGY ACQUISIT
ValueSharesWeighting
Q4 2022$6,003
+20.1%
6000.0%0.00%
Q3 2022$5,0000.0%6000.0%0.00%
Q2 2022$5,0000.0%6000.0%0.00%
Q1 2022$5,0000.0%6000.0%0.00%
Q4 2021$5,0000.0%6000.0%0.00%
Q3 2021$5,0000.0%6000.0%0.00%
Q2 2021$5,0000.0%6000.0%0.00%
Q1 2021$5,0006000.00%
Other shareholders
EPIPHANY TECHNOLOGY ACQUISIT shareholders Q1 2023
NameSharesValueWeighting ↓
Hawkeye Capital Management, LLC 632,138$6,208,0003.39%
RP Investment Advisors LP 804,057$7,896,0001.11%
HGC Investment Management Inc. 3,430,000$33,684,0001.03%
Sage Rock Capital Management LP 359,298$3,528,0000.70%
Privium Fund Management (UK) Ltd 51,000$501,0000.57%
Saba Capital Management, L.P. 3,804,539$37,361,0000.44%
CVI Holdings, LLC 568,882$5,586,0000.41%
Castle Creek Arbitrage, LLC 728,652$7,155,0000.39%
BASSO CAPITAL MANAGEMENT, L.P. 373,790$3,671,0000.38%
ARISTEIA CAPITAL, L.L.C. 2,011,452$19,752,0000.35%
View complete list of EPIPHANY TECHNOLOGY ACQUISIT shareholders